Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
NCT00568529
·
clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
30
Enrollment
OTHER
Sponsor class
Stopped
There are not enough patients enrolled.
Conditions
Gastric Cancer
Interventions
DRUG:
Capecitabine and Oxaliplatin
Sponsor
Fudan University